Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
British guidelines recommend that inhaled short acting
2 agonists should be the first line treatment for
asthma. On p 47 Strube argues for inhaled steroids to be used first:
although bronchodilating
2 agonists give temporary
clinical improvement, underlying airway inflammation persists and could
produce long term structural lung damage. Early intervention with
inhaled steroids could prevent this, he says. In response Rudolph
argues that this hypothesis is unproved and that the treatment
guidelines may be being misunderstood.